semaglutide ckd trial — Blog — NephJC FLOWing with the SemagluTIDE —

The direct links between measurable TRE-induced circadian changes and bone health outcomes require elucidation

When you are constantly experiencing things like pain, dehydration and nausea, including regular IV therapy appointments in your treatment plan could be effective for ongoing symptom management

For context on the broader regulatory environment affecting research compounds, the research peptides legal status 2026 guide provides essential background

Here we develop a series of peptides closely related to the GLP-1 homolog exendin-4, used clinically as exenatide 12 , but with widely varying trafficking properties

Extensive cardiovascular outcome trials have demonstrated that certain GLP-1 receptor agonists can reduce cardiovascular risk